Abstract:Purpose: To compare the hippocampus (HPC) dose reduced by HPC-sparing intensity modulated radiation therapy (IMRT) plans between nasopharyngeal carcinoma (NPC) patients of stages T1-T2 and T3-T4, and to investigate the correlation between the dose of the HPC and the volume of PTVnx70 (the planning target volume of the primary tumor in the nasopharynx that received 70 Gy). Methods and Materials: Fifty-eight NPC patients were retrospectively evaluated. HPC-nonsparing IMRT or sparing IMRT for each patient was designed according to the protocol for NPC. Dose-volume histogram was used to evaluate the IMRT plans for each patient. The difference in values of HPC parameters (eg, D-min[NS] - D-min[S]) between HPC-sparing and nonsparing plans in the stage T1-T2 group and stage T3-T4 group were compared. The correlations between the dose of the HPC and the volume of PTVnx70 were analyzed. Results: There was no significance between HPC-sparing and nonsparing IMRT plans. Compared with the HPC-nonsparing plans, the HPC-sparing plans significantly decreased both dosimetric and volumetric parameters for the HPC (P < .05), except for D-min, D-98%,D- and V-5. The medians of D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-30[NS] - V-30[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] in the T1-T2 group were significantly lower than in the T3-T4 group (P < .05), respectively. Both dosimetric and volumetric parameters for the HPC were positively correlated with the volume of PTVnx70 in HPC-sparing and HPC-nonsparing plans (P < .05). The volume of PTVnx70 was positively correlated with D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] (P < .05). Conclusions: HPC-sparing IMRT plans may play a more significant role in decreasing D-median, D-mean, D-40%,D- and V-30-V-50 of HPC in NPC patients with stages T3-T4 than those in stages T1-T2. PTVnx70 volume of NPC patients is positively correlated with all dosimetric and volumetric parameters of HPC and the reduction of specific dosage parameters by HPC-sparing IMRT plans. (c) 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Thyroid Dose‐volume Thresholds for the Risk of Radiation‐related Hypothyroidism in Nasopharyngeal Carcinoma Treated with Intensity‐modulated Radiotherapy—a Single‐institution Study

Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Predictors of Radiation-induced Hypothyroidism in Nasopharyngeal Carcinoma Survivors after Intensity-modulated Radiotherapy

Thyroid V50 is a Risk Factor for Hypothyroidism in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy: a Retrospective Study

Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial

Hypothalamic–pituitary–thyroid Dysfunction Induced by Intensity-Modulated Radiotherapy (IMRT) for Adult Patients with Nasopharyngeal Carcinoma

Multivariate NTCP Model of Hypothyroidism after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

Study of related factors of radiation-induced hypothyroidism in nasopharyngeal carcinoma

Prioritizing Sufficient Dose to Gross Tumor Volume over Normal Tissue Sparing in Intensity-Modulated Radiotherapy Treatment of T4 Nasopharyngeal Carcinoma.

Risk Factors of Early Thyroid Dysfunction after Definitive Radiotherapy in Nasopharyngeal Carcinoma Patients

Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation

Early screening of high-risk patients with radiation-induced hypothyroidism in nasopharyngeal carcinoma by hematological examination

Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose

Radiation-Induced Hypothyroidism in Patients With Breast Cancer After Hypofractionated Radiation Therapy: A Prospective Cohort Study

Impact of Minimum Point Dose on Local Control and Toxicity in T3–4 Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy Plus Chemotherapy

Why Subclinical Involvement is Prescribed the Same High Dose As Gross Tumor Volume: A Study on High‐dose Clinical Target Volume in Intensity‐modulated Radiotherapy Plan of Nasopharyngeal Carcinoma

Radiation-Induced Temporal Lobe Injury after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma Patients: A Dose-Volume-Outcome Analysis

Analysis of Dosimetric Factors Associated with Temporal Lobe Necrosis (TLN) in Patients with Nasopharyngeal Carcinoma (NPC) after Intensity Modulated Radiotherapy

Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors